PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Sarcoidosis D012507 13 associated lipids
Pleurisy D010998 20 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Cataract D002386 34 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Sarcoma 180 D012510 21 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Precancerous Conditions D011230 48 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Hypotension D007022 41 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Coronary Disease D003327 70 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Rhinitis D012220 10 associated lipids
Melanoma D008545 69 associated lipids
Asthma D001249 52 associated lipids
Hyperemia D006940 25 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Leukemia P388 D007941 43 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Thrombosis D013927 49 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Myocardial Infarction D009203 21 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
el-Lati SG et al. Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells. 1994 J. Invest. Dermatol. pmid:7513741
Warren JB et al. PGD2 is an intermediate in agonist-stimulated nitric oxide release in rabbit skin microcirculation. 1994 Am. J. Physiol. pmid:7515584
D'Onofrio C et al. Antiproliferative activity of cyclopentenone prostaglandins in early HTLV-1 infection is independent of IL-2 and is associated with HSP70 induction. 1994 Leukemia pmid:7516027
Okayama Y et al. In vitro effects of H1-antihistamines on histamine and PGD2 release from mast cells of human lung, tonsil, and skin. 1994 Allergy pmid:7518654
Darius H et al. Inhibition of human platelets and polymorphonuclear neutrophils by the potent and metabolically stable prostaglandin D2 analog ZK 118.182. 1994 Eur. J. Pharmacol. pmid:7522176
Polosa R et al. [Mast cell mediator release after endobronchial challenge with adenosine 5'-monophosphate in asthmatic subjects]. 1994 Apr-Jun Ann. Ital. Med. Int. pmid:7522500
Takei M and Endo K Histamine release and calcium concentrations in rat mast cells are dependent on intracellular ATP: effects of prostaglandin D2. 1994 Prostaglandins Leukot. Essent. Fatty Acids pmid:7524104
Ko FN et al. YC-1, a novel activator of platelet guanylate cyclase. 1994 Blood pmid:7527671
Kaye AD et al. Analysis of thromboxane receptor-mediated responses in the feline pulmonary vascular bed. 1995 Crit. Care Med. pmid:7528116
Patella V et al. Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization. 1995 J. Immunol. pmid:7533185
Crankshaw DJ and Gaspar V Pharmacological characterization in vitro of prostanoid receptors in the myometrium of nonpregnant ewes. 1995 J. Reprod. Fertil. pmid:7535849
Leal-Berumen I et al. Prostanoid enhancement of interleukin-6 production by rat peritoneal mast cells. 1995 J. Immunol. pmid:7536779
Parker J et al. Antiviral effect of cyclopentenone prostaglandins on vesicular stomatitis virus replication. 1995 Antiviral Res. pmid:7537950
Murakami M et al. The immediate phase of c-kit ligand stimulation of mouse bone marrow-derived mast cells elicits rapid leukotriene C4 generation through posttranslational activation of cytosolic phospholipase A2 and 5-lipoxygenase. 1995 J. Exp. Med. pmid:7540649
Murakami M et al. Interleukin 4 suppresses c-kit ligand-induced expression of cytosolic phospholipase A2 and prostaglandin endoperoxide synthase 2 and their roles in separate pathways of eicosanoid synthesis in mouse bone marrow-derived mast cells. 1995 Proc. Natl. Acad. Sci. U.S.A. pmid:7541141
Marone G et al. Human heart mast cells in anaphylaxis and cardiovascular disease. 1995 May-Jun Int. Arch. Allergy Immunol. pmid:7542106
Horn EH et al. Longitudinal studies of platelet cyclic AMP during healthy pregnancy and pregnancies at risk of pre-eclampsia. 1995 Clin. Sci. pmid:7545563
Charlesworth EN Role of basophils and mast cells in acute and late reactions in the skin. 1995 Chem. Immunol. pmid:7546286
Ko FN et al. Inhibition on platelet activation by shikonin derivatives isolated from Arnebia euchroma. 1995 Biochim. Biophys. Acta pmid:7548232
Reanmongkol W et al. Inhibitory effect of alkaloids extracted from the stem bark of Hunteria zeylanica on 5-lipoxygenase activity in vitro. 1995 Biol. Pharm. Bull. pmid:7550132
Negishi M et al. Involvement of protein kinase in delta 12-prostaglandin J2-induced expression of rat heme oxygenase-1 gene. 1995 FEBS Lett. pmid:7556684
Murakami M et al. Interleukin-3 regulates development of the 5-lipoxygenase/leukotriene C4 synthase pathway in mouse mast cells. 1995 J. Biol. Chem. pmid:7559381
Rabe KF et al. Hydrogen peroxide contracts human airways in vitro: role of epithelium. 1995 Am. J. Physiol. pmid:7573466
Hartmann K et al. Effect of CC chemokines on mediator release from human skin mast cells and basophils. 1995 Int. Arch. Allergy Immunol. pmid:7580286
De Vries GW et al. An EP receptor with a novel pharmacological profile in the T-cell line Jurkat. 1995 Br. J. Pharmacol. pmid:7582550
Hespeling U et al. Feedback-inhibition of glucagon-stimulated glycogenolysis in hepatocyte/Kupffer cell cocultures by glucagon-elicited prostaglandin production in Kupffer cells. 1995 Hepatology pmid:7590678
Murakami M et al. IgE-dependent activation of cytokine-primed mouse cultured mast cells induces a delayed phase of prostaglandin D2 generation via prostaglandin endoperoxide synthase-2. 1995 J. Immunol. pmid:7594606
Terao A et al. Roles of prostaglandins D2 and E2 in interleukin-1-induced activation of norepinephrine turnover in the brain and peripheral organs of rats. 1995 J. Neurochem. pmid:7595573
Matsumoto K et al. Novel function of prostaglandins as inducers of gene expression of HGF and putative mediators of tissue regeneration. 1995 J. Biochem. pmid:7608139
Kawata R et al. Prostaglandin synthase 1 and prostaglandin synthase 2 both participate in activation-induced prostaglandin D2 production in mast cells. 1995 J. Immunol. pmid:7608559
Peden DB and Dailey L Modulation of mast cell functions by in vitro ozone exposure. 1995 Am. J. Physiol. pmid:7611432
Serrero G and Lepak NM Prostaglandin F2 alpha inhibits epidermal growth factor binding to cellular receptors on adipocyte precursors in primary culture. 1995 Biochem. Biophys. Res. Commun. pmid:7626101
Lee JH et al. Induction of p53 and apoptosis by delta 12-PGJ2 in human hepatocarcinoma SK-HEP-1 cells. 1995 FEBS Lett. pmid:7628635
Ikai K et al. Effect of cytotoxic prostaglandin, delta 12-prostaglandin J2 on E-cadherin expression in transformed epidermal cells in culture. 1995 Prostaglandins Leukot. Essent. Fatty Acids pmid:7630918
Hu ZQ et al. An essential role of prostaglandin E on mouse mast cell induction. 1995 J. Immunol. pmid:7636261
Araki M et al. Isoflurane modulates phorbol myristate acetate-, prostaglandin D2-, and prostaglandin E2-induced alterations in hepatic flow and metabolism in the perfused liver in fasted rats. 1994 Anesth. Analg. pmid:7639362
Boie Y et al. Molecular cloning and characterization of the human prostanoid DP receptor. 1995 J. Biol. Chem. pmid:7642548
Pandey HP et al. Circadian variations of prostaglandins D2, E2, and F2 alpha in the cerebrospinal fluid of anesthetized rats. 1995 Biochem. Biophys. Res. Commun. pmid:7646520
Refsnes M et al. On the mechanisms of the growth-promoting effect of prostaglandins in hepatocytes: the relationship between stimulation of DNA synthesis and signaling mediated by adenylyl cyclase and phosphoinositide-specific phospholipase C. 1995 J. Cell. Physiol. pmid:7650056
Koizumi T et al. Identification of a cis-regulatory element for delta 12-prostaglandin J2-induced expression of the rat heme oxygenase gene. 1995 J. Biol. Chem. pmid:7665598
Bull HA et al. Basophil mediator release in atopic dermatitis. 1993 J. Invest. Dermatol. pmid:7680056
Campbell AM et al. Modulation of eicosanoid and histamine release from human dispersed lung cells by terfenadine. 1993 Allergy pmid:7681268
Campbell AM et al. Conjunctival provocation tests with codeine phosphate. Effect of disodium cromoglycate. 1993 Ann Allergy pmid:7687104
Charlesworth EN et al. Cutaneous late-phase response in food-allergic children and adolescents with atopic dermatitis. 1993 Clin. Exp. Allergy pmid:7687509
al-Laith M and Pearce FL On the mechanism of action of sodium orthovanadate in inducing histamine release from rat peritoneal mast cells. 1993 Int. Arch. Allergy Immunol. pmid:7689004
Marone G et al. Mechanisms of activation of human mast cells and basophils by general anesthetic drugs. 1993 Ann Fr Anesth Reanim pmid:7690200
Naclerio RM Effects of antihistamines on inflammatory mediators. 1993 Ann Allergy pmid:7690526
Maxwell DL et al. Inhaled nedocromil sodium reduces histamine release from isolated large airway segments of asthmatic subjects in vivo. 1993 Eur. Respir. J. pmid:7693506
Satoh S et al. Promotion of sleep by prostaglandin D2 in rats made insomniac by pretreatment with para-chlorophenylalanine. 1994 Neurosci. Res. pmid:7708292
Leifke E et al. In vivo comparative study of the seizure- and ischemia-induced synthesis of eicosanoids in the brain of gerbils. 1994 Sep-Oct Arch Int Pharmacodyn Ther pmid:7710301